Moreover, analysis of AD brains has demonstrated that both frontal and temporal regions exhibit a significant increase in NOX2 activity and in NOX2 cytosolic subunits expression throughout the disease progression, most notably in the more advanced stages of the disease. The gene discussed is CYBB; the disease is Alzheimer disease.